Your source for all Prime Therapeutics' December 2025 Drug Insights publications.

Prime Therapeutics (Prime) provides you with regular updates on the drug pipeline as well as next-generation clinical information and hot topics. The following Drug Insights publications for December 2025 will keep you informed on what’s trending now and trending clinical topics. 

---

Released Dec. 1, 2025

Trending Topics & Drug Approvals: December 2025

Prime covers hot topics and the latest specialty and traditional drug approvals. The latest edition covers details behind the U.S. Food and Drug Administration's (FDA) move to initiate removal of Boxed Warnings for cardiovascular (CV) diseases, breast cancer and probable dimentia from hormone replacement therapy (HRT). 

---

Released Dec. 2, 2025

Watch List

A monthly report of the most notable drugs that may significantly affect the populations we serve. Drug highlights this month are etuvetidigene autotemcel, marnetegragene autotemcel and more.

---

Released Dec. 10, 2025

Expert Clinical Network Insights: December 2025

Committed to keeping you informed on the latest specialty drug insights from leading experts, this newsletter features analysis of the FDA's approval of zopapogene imadenovec-drba for the treatment of adults with recurrent respiratory papillomatosis (RRP). 

---

Looking for previous 2025 drug insights publications?

Simply click on the month to access past editions of our drug insights.

November 2025

October 2025

September 2025

August 2025

July 2025

June 2025

May 2025

April 2025

March 2025

February 2025

January 2025